Jump to: Page Content, Site Navigation, Site Search,
You are seeing this message because your web browser does not support basic web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
Published 28 November 2008, doi:10.1136/bmj.a531
Cite this as: BMJ 2008;337:a531
May Ching Soh, rheumatology research registrar1, Michael Croxson, endocrinologist2
1 Department of Medicine, North Shore Hospital, Auckland, New Zealand, 2 Department of Endocrinology, Greenlane Clinical Centre, Auckland
Correspondence to: M Croxson, Thyroid Clinic, Greenlane Clinical Centre, PO Box 92-189, Auckland, New Zealand MichaelC@adhb.govt.nz
β blockers may precipitate circulatory collapse in thyrotoxic patients with low output heart failure
| The first 150 words of the full text of this article appear below. |
Epidemiological studies show an excess vascular mortality associated with hyperthyroidism, even after radioiodine treatment, and in people aged under 50.1 2 Thyrotoxic cardiomyopathy is a distinct clinical entity with devastating clinical consequences. It can affect young people even in the absence of underlying cardiac disease.3 4 It often presents as heart failure. Most cases are reversible, with cardiac function improving after thyroid function returns to normal.4 5 6 7 However, in the acute setting, the severity of the illness may result in fatalities despite treatment.8 9 10 This represents an important exception to the general principle that β blockers should be used in most hyperthyroid patients with tachyarrhythmias.
We present the case of a young man with chronic hyperthyroid Graves disease, who was admitted to hospital with severe heart failure, rapid atrial fibrillation, and pneumonia and died despite resuscitation.
A man in his 20s with known hyperthyroid Graves disease was admitted to hospital critically ill after five
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
StumbleUpon
Technorati What's this?
Read all Rapid Responses